Tobias L Freitag International Celiac Disease Symposium 2026

Abstracts this author is presenting:

• In Vivo Evaluation of a Multi-Epitope Gliadin Peptide Construct as a Novel Drug Substance Candidate for Epicutaneous Immunotherapy (EPIT) in Celiac Disease — Lunch & Elevated Poster Presentation Session 1